Siemens, Varian ink global partnership

Lisa Fratt | | Health Exec | Precision Medicine
acquisition, alliance, partnership - 13.78 Kb
Varian Medical Systems and Siemens Healthcare have signed a global partnership to provide diagnostic and therapeutic systems and services for treating cancer with image-guided radiotherapy and radiosurgery.

The collaboration covers the mutual marketing and representation of products for imaging and treatment in the global radiation oncology business. This collaboration further comprises the development of software interfaces between Siemens and Varian treatment systems.

The two companies also will investigate opportunities for joint development of new products for image-guided radiotherapy and radiosurgery. Under the agreement, Varian will represent Siemens diagnostic imaging products such as CT, PET/CT or MRI to radiation oncology clinics around the world beginning immediately in most international markets and expanding to North America later in 2012.

Siemens will similarly represent Varian equipment and software for radiotherapy and radiosurgery within its offerings to its healthcare customers.

Furthermore, Varian and Siemens will develop interfaces that will enable connecting Varian’s Aria oncology information system software with Siemens accelerators and imaging systems.

Lisa Fratt

Related Content

Pitching the business case for 3D printing labs in radiology
FDA issues first-ever clearance for OTC oximeter
Augmented reality company secures $15M in funding from Cleveland Clinic, Mayo, GE Healthcare and more
Merck to acquire Prometheus Biosciences for $10.8B
Johnson & Johnson scraps RSV vaccine after trial
Intermountain Health launches new biotech company

Around the web

Cardiovascular Business
Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

AI in Healthcare
A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

Cardiovascular Business
FDA commissioner urges clinicians to join fight against medical misinformation

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Design by Adaptive Theme
Trimed Popup
Trimed Popup